期刊文献+

肝硬化患者血清脂联素水平及其与胰岛素、肿瘤坏死因子-α的关系 被引量:2

Levels of adiponectin and their relation with insulin and tumor necrosis factor-α in cirrhosis
下载PDF
导出
摘要 目的观察肝硬化患者血清脂联素水平及其与胰岛素、肿瘤坏死因子-α的关系。方法测定73例肝硬化患者(肝硬化组)和30例健康体检者(对照组)的血清脂联素、胰岛素和肿瘤坏死因子-α及相关的临床生化指标,同时对肝硬化患者按Child-Pugh分级标准进行肝功能分级。结果肝硬化组血清脂联素水平明显高于对照组(P<0.01);脂联素水平与胰岛素水平呈正相关,与胰岛素敏感指数呈负相关,与肿瘤坏死因子-α、肝功能分级无关。结论肝硬化患者血清脂联素水平明显升高,其改变与胰岛素敏感性相关,与肿瘤坏死因子-α、肝功能分级无关。 Objective To investigate the levels of adiponectin and the relation with insulin and tumor necrosis factor(TNF) - α in patients with cirrhosis. Methods Adiponectin,insulin and TNF - α levels were determined in 73 patients with cirrhosis and 30 healthy controls, and were correlated with various clinical and biochemical parameters. Meanwhile Child - Pugh liver function was classified. Resuits Adiponectin was significantly elevated in patients with cirrhosis compared with the control. Adiponectin levels in cirrhosis was correlated positively with insulin and negatively with insulin sensitively index, and did not correlate with TNF - α and liver function. Conclusion Serum adiponectin levels in cirrhosis are significantly elevated. Adiponectin levels do not correlate with TNF -α and liver function, but exclusively insulin and insulin sensitivity index.
出处 《中国医师进修杂志(内科版)》 2006年第12期23-24,共2页 Chinese Journal of Postgraduates of Medicine
基金 上海市科学技术委员会资助项目(054119625)
关键词 肝硬化 脂联素 胰岛素 肿瘤坏死因子 Cirrhosis Adiponectin Insulin Tumor necrosis factor
  • 相关文献

参考文献6

二级参考文献14

  • 1陈名道.心血管内分泌学:内分泌医师面临的挑战[J].中华内分泌代谢杂志,2005,21(1):1-4. 被引量:28
  • 2Kershaw EE,Flier JS.Adipose tissue as an endocrine organ.J Clin Endocrinol Metab,2004,80:2548-2556.
  • 3Licinio J,Caglayna S,Ozata M,et al.Phenotypic effects of leptin replacement on morbid obesity,diabetes mellitus,hypogonadism,and behavior in leptin-deficient adults.Proc Natl Acad Sci U S A,2004,101:4531-4536.
  • 4Turjillo ME,Scherer PE.Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolism.J Inter Med,2005,257:167-175.
  • 5Baneyee RR,Rangwala SM,Shapiro JS,et al.Regulation of fasted blood glucose by resistin.Science,2004,303:1195-1198.
  • 6Ofei F,Hruel S,Newkink J,et al.Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.Diabetes,1996,45:881-885.
  • 7Wallanius K,Jansson JO,Wallenius V.The therapeutic potential of interleukin-6 in treating obesity.Expert Opin Biol Ther,2003,3:1061-1070.
  • 8Yang R,Xu A,Pray J,et al.Cloning of omentin,a new adipocytokine from omental fat tissue in human.Diabetes,2005,52 Suppl 1:A1.
  • 9Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin.Science,2005,307:426-430.
  • 10Ma LJ,Mao SL,Taylor KL,et al.Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.Diabetes,2004,53:336-346.

共引文献16128

同被引文献15

  • 1杨文英.加强胰岛细胞胰岛素抵抗的研究[J].中华医学杂志,2006,86(36):2521-2523. 被引量:21
  • 2曾明德,萧树东.肝脏与内分泌[M].第1版,北京:人民卫生出版社,1995,184.
  • 3Hui CK,Zhang HY,Lee NP,et al.Serum adiponectinis increased in advancing liver fibrosis and declines witllreduction in fibrosis in chronic hepatitis B[J].J Hepatol, 2007.47(2) : 191-202.
  • 4Wang Z, Scherer PE. Adiponectin,cardiovascular function,and hypertension[J]. Hypertension,2008,51(7) :8-14.
  • 5Arya MS,George B,Joel MN, et al . Single-pill combinationof telmisartan/amlodipine versus amlodipine monotherapy indiabetic hypertensive patients;an 8-week randomized,parallel-group. double-blind trial[J]. Clinical Therapeutics , 2012, 34(3):537-551.
  • 6Liu Y, Michael MD, Kash Sy et al . Deficiency of adiponectinreceptor 2 reduces diet-induced insulin resistance but promotestype 2 diabetes[J]. Endocrinology ,2007,148(2) : 683-692.
  • 7Fasshauer M,Klein J,Neumann S,et al , Adiponectin geneexpression is inhibited by p-adrenergic stimulation via proteinkinase A in 3T3-L1 adipocytes [J]. FEBS Lett , 2010, 507(2):142-146.
  • 8Massiera F,Bloch FM,Ceiler et al . Adipose angiotensino-gen is involved in adipose tissue growth and blood pressureregulation[J]. FASEB J,2001,15(4) :2727-2729.
  • 9Amr AF, Abdulruhman SA,Iyad] j et al . Therapeutic role oftelmisartan against acetaminophen hepatotoxicity in mice[J].Eur J Pharmacol,2012,693(1) : 64-71.
  • 10杨秀春,刘凡,崔炜,都军,谢瑞芹,宗义君.脂联素、瘦素、血脂、体质量指数和腰臀比与女性冠心病的关系[J].河北医科大学学报,2008,29(5):641-643. 被引量:7

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部